UK Approves Bayer's Drug Elinzanetant (Lynkuet) for Treating Menopausal Vasomotor Symptoms
1 week ago /
Read about 0 minute
Author:小编
Bayer's medication, Elinzanetant (Lynkuet), has secured approval in the United Kingdom for the management of moderate to severe vasomotor symptoms during menopause, offering the promise of alleviating associated sleep disturbances.